NIH R01 · 2025
Relapse after Discontinuation of Antipsychotics during Pregnancy (R-DAP study)
Project Summary There is an increase in psychotropic medication use in women in their fertile ages. Due to concerns for the developing fetus, half of women decide to discontinue their medication before- or at the beginning of pregnancy. While the wish to avoid in utero medication exposure to the fetus is understandable, discontinuation of medication might lead to relapse, which can have a profound negative impact on the health of mother and child. In our prior R01, we showed that relapse risks were relatively limited for women with unipolar depression who chose to discontinue their antidepressant medication before or during pregnancy. In addition, we found limited risks for those women who…
From the public funding record at NIH RePORTER. Describes the funded project, not the reviews below.